LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

Home・Akcijų sąrašas・Vivani Medical

Vivani Medical

Uždarymo kaina

1.2 11.11

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.11

Max

1.25

Pagrindiniai rodikliai
By Trading Economics
Pajamos	614K -6.5M
Darbuotojai	37

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-30

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-25M 79M
Ankstesnė atidarymo kaina	-9.91
Ankstesnė uždarymo kaina	1.2

Vivani Medical Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-15 21:14; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Central Bank Decisions -2-

2026-03-15 21:14; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

2026-03-16 00:00; UTC

Svarbiausios naujienos

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

2026-03-15 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

2026-03-15 23:44; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

2026-03-15 23:35; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

2026-03-15 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

2026-03-15 22:37; UTC

Rinkos pokalbiai

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

2026-03-15 22:18; UTC

Rinkos pokalbiai

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

2026-03-15 22:14; UTC

Uždarbis

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

2026-03-15 22:14; UTC

Uždarbis

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

2026-03-15 22:14; UTC

Uždarbis

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

2026-03-15 22:14; UTC

Uždarbis

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

2026-03-15 22:14; UTC

Uždarbis

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

2026-03-15 22:00; UTC

Svarbiausios naujienos

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

2026-03-15 22:00; UTC

Svarbiausios naujienos

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

2026-03-15 03:00; UTC

Svarbiausios naujienos

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

2026-03-14 15:00; UTC

Svarbiausios naujienos

Iran War Delivers Windfall to America's Oil Country -- WSJ

2026-03-14 02:03; UTC

Uždarbis

This Copper Stock Is Worth Mining for Profits -- Barrons.com

2026-03-14 01:32; UTC

Įsigijimai, susijungimai, perėmimai

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

2026-03-14 00:29; UTC

Įsigijimai, susijungimai, perėmimai

13D Filings -- Barrons.com

2026-03-13 22:27; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

2026-03-13 22:13; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

2026-03-13 22:04; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

2026-03-13 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

2026-03-13 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-13 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Financial Services Roundup: Market Talk

2026-03-13 20:02; UTC

Rinkos pokalbiai

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

2026-03-13 19:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

2026-03-13 19:35; UTC

Svarbiausios naujienos

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Vivani Medical Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių Vivani Medical akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Ikimokestinis pelnas

Pardavimai

Veiklos pelnas

Apie bendrovę Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.